Global Collaboration Reshape Biotech enables researchers to collaborate across borders, accelerating experiments and boosting throughput. This capability resonates with multinational biotech and pharma R&D teams seeking distributed workflows and faster iteration cycles. Sales opportunities include multi site deployments, integrations with LIMS or ELN systems, and expanding use of the Organism Library for data driven decisions.

Product Suite Expansion Recent launches like a revamped imaging system and automated media plate filler show a growing automation product line. Target opportunities include upselling new automation modules to existing customers and expanding into labs in food, agriculture, and biologicals. Consider offering services and support that lock in usage, along with data analytics tied to imaging and automation data.

Investor Backing The company is backed by notable investors and an accelerator, signaling credibility with enterprise buyers. Use this to support credibility in outreach to CFOs and procurement teams and to explore co marketing or channel partnerships with investor networks.

Market Positioning Customers include global leaders in food, agriculture and biologicals, with a Copenhagen base and EU expansion potential. The sustainability focus and ability to accelerate discovery in alternative protein and sustainable agriculture create a compelling value proposition for labs, contract manufacturers, and academic partners seeking scalable automation. Tailor messaging for EU funding programs and large scale biotech initiatives.

Technology Readiness A software and hardware stack built on REST, modern web tech and Linux provides a versatile integration footprint. This readiness supports LIMS/ELN integration, remote monitoring, and cloud based analytics, making it attractive to labs seeking plug and play automation. Sales plays include integration services, managed automation solutions and data driven workflow optimization.